Resectable Mucosal Melanomas clinical trials

Explore recruiting resectable mucosal melanomas clinical trials.

Recruiting resectable mucosal melanomas studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Resectable Mucosal Melanomas trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase II multicentric study: efficacy evaluation of neo-adjuvant treatment associated with maintenance therapy by anti-PD1 immunotherapy on disease-free-survival (DFS) in patients with resectable mucosal melanoma (IMMUQ)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Resectable Mucosal Melanomas trials by city

Resectable Mucosal Melanomas in Toronto Resectable Mucosal Melanomas in Vancouver Resectable Mucosal Melanomas in Montreal Resectable Mucosal Melanomas in Calgary Resectable Mucosal Melanomas in Edmonton Resectable Mucosal Melanomas in Ottawa Resectable Mucosal Melanomas in Winnipeg Resectable Mucosal Melanomas in Quebec City Resectable Mucosal Melanomas in Hamilton Resectable Mucosal Melanomas in Kitchener Resectable Mucosal Melanomas in London Resectable Mucosal Melanomas in Halifax Resectable Mucosal Melanomas in New York Resectable Mucosal Melanomas in Los Angeles Resectable Mucosal Melanomas in Chicago Resectable Mucosal Melanomas in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease